Concepedia

Adam B. Weinglass

AB

Statistics

Publications

29

Citations

1.5K

H-Index

21

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Howard Hughes Medical Institute

University of California, Los Angeles

United States Military Academy

National Institutes of Health

Adam B. Weinglass is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, biochemistry, and pharmacology.

Publications per year

1999–2025

29

Publications

29

ProTx-II, a Selective Inhibitor of NaV1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors

William A. Schmalhofer, Jeffrey D. Calhoun, Rachel Burrows et al. · Molecular Pharmacology · 2008 · 304 citations

, , +17

GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo

M. Hauge, M. A. Vestmar, Anna Sofie Husted et al. · Molecular Metabolism · 2014 · 208 citations · Full text

, , +17

Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40

Jun Lu, Noel Byrne, John Wang et al. · Nature Structural & Molecular Biology · 2017 · 194 citations

, , +16

Extracellular loop C of NPC1L1 is important for binding to ezetimibe

Adam B. Weinglass, Martin Köhler, Uwe Schulte et al. · Proceedings of the National Academy of Sciences · 2008 · 115 citations · Full text

, , +17

Engineering a terbium-binding site into an integral membrane protein for luminescence energy transfer

José Luís Vázquez, Adam B. Weinglass, H. Ronald Kaback · Proceedings of the National Academy of Sciences · 2002 · 58 citations

, , +13

1–5 of 29